Headlines & Research Highlights
Innovate BC has announced $300,000 in funding through the Ignite program for TRIUMF and ARTMS to further develop and validate the production of zirconium-89 (Zr-89) for use in PET imaging scans for cancer patients eligible for immuno-oncology (IO) therapies.
Dr. Smith will begin his 5-year term as TRIUMF Director on May 17, 2021.
An international team that includes researchers from TRIUMF has published new measurements for the exclusion limits for sterile neutrinos.
A new paper published by TRIUMF Theory Department scientist Jason Holt and colleagues from the University of Washington and Germany has provided first-principles predictions of which isotopes can and can’t exist for elements from helium to iron.